202 related articles for article (PubMed ID: 33621210)
21. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
22. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.
Lutskiy MI; Beardsley DS; Rosen FS; Remold-O'Donnell E
Blood; 2005 Oct; 106(8):2815-7. PubMed ID: 15985539
[TBL] [Abstract][Full Text] [Related]
23. The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling.
Calvez R; Lafouresse F; De Meester J; Galy A; Valitutti S; Dupré L
Haematologica; 2011 Oct; 96(10):1415-23. PubMed ID: 21659358
[TBL] [Abstract][Full Text] [Related]
24. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
25. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein.
de Noronha S; Hardy S; Sinclair J; Blundell MP; Strid J; Schulz O; Zwirner J; Jones GE; Katz DR; Kinnon C; Thrasher AJ
Blood; 2005 Feb; 105(4):1590-7. PubMed ID: 15494425
[TBL] [Abstract][Full Text] [Related]
26. The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets.
De Meester J; Calvez R; Valitutti S; Dupré L
J Leukoc Biol; 2010 Nov; 88(5):1031-40. PubMed ID: 20689099
[TBL] [Abstract][Full Text] [Related]
27. WASP: a key immunological multitasker.
Thrasher AJ; Burns SO
Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
[TBL] [Abstract][Full Text] [Related]
28. Defective thymic output in WAS patients is associated with abnormal actin organization.
Li W; Sun X; Wang J; Zhao Q; Dai R; Wang Y; Zhou L; Westerberg L; Ding Y; Zhao X; Liu C
Sci Rep; 2017 Sep; 7(1):11978. PubMed ID: 28931895
[TBL] [Abstract][Full Text] [Related]
29. Modelling of human Wiskott-Aldrich syndrome protein mutants in zebrafish larvae using in vivo live imaging.
Jones RA; Feng Y; Worth AJ; Thrasher AJ; Burns SO; Martin P
J Cell Sci; 2013 Sep; 126(Pt 18):4077-84. PubMed ID: 23868979
[TBL] [Abstract][Full Text] [Related]
30. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
Jain N; George B; Thanabalu T
Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
[TBL] [Abstract][Full Text] [Related]
31. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
32. Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome.
Zhang X; Dai R; Li W; Zhao H; Zhang Y; Zhou L; Du H; Luo G; Wu J; Niu L; An Y; Zhang Z; Ding Y; Song W; Liu C; Zhao X
Blood; 2016 Jun; 127(25):3180-91. PubMed ID: 27170596
[TBL] [Abstract][Full Text] [Related]
33. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation.
Badour K; Zhang J; Shi F; Leng Y; Collins M; Siminovitch KA
J Exp Med; 2004 Jan; 199(1):99-112. PubMed ID: 14707117
[TBL] [Abstract][Full Text] [Related]
34. Wiskott-Aldrich syndrome in a female.
Lutskiy MI; Sasahara Y; Kenney DM; Rosen FS; Remold-O'Donnell E
Blood; 2002 Oct; 100(8):2763-8. PubMed ID: 12351383
[TBL] [Abstract][Full Text] [Related]
35. Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.
Matalon O; Reicher B; Barda-Saad M
Immunol Rev; 2013 Nov; 256(1):10-29. PubMed ID: 24117810
[TBL] [Abstract][Full Text] [Related]
36. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements.
Sato M; Tsuji NM; Gotoh H; Yamashita K; Hashimoto K; Tadotsu N; Yamanaka H; Sekikawa K; Hashimoto Y
J Immunol; 2001 Oct; 167(8):4701-9. PubMed ID: 11591801
[TBL] [Abstract][Full Text] [Related]
38. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
39. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
40. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect.
Gismondi A; Cifaldi L; Mazza C; Giliani S; Parolini S; Morrone S; Jacobelli J; Bandiera E; Notarangelo L; Santoni A
Blood; 2004 Jul; 104(2):436-43. PubMed ID: 15001467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
